These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3878162)

  • 21. Deoxyadenosine (AdR) inhibition of newly activated lymphocytes: blockade at the G0-G1 interface.
    Redelman D; Bluestein HG; Cohen AH; Depper JM; Wormsley S
    J Immunol; 1984 Apr; 132(4):2030-8. PubMed ID: 6421932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of diucifon on the hematopoietic and immune systems in normal and irradiated organisms].
    Kostiuk LE; Semina OV; Kurilets ES; Poverennyĭ AM; Goloshchapov NM
    Radiobiologiia; 1984; 24(5):687-90. PubMed ID: 6334330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective effects of interferon on distinct sites of the T lymphocyte triggering process.
    Leanderson T; Hillörn V; Holmberg D; Larsson EL; Lundgren E
    J Immunol; 1982 Aug; 129(2):490-4. PubMed ID: 6177767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell growth factor (TCGF).
    Sarin PS; Gallo RC
    Crit Rev Immunol; 1984; 4(4):279-305. PubMed ID: 6232114
    [No Abstract]   [Full Text] [Related]  

  • 25. Synovial fluid transforming growth factor beta inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis.
    Summers KL; O'Donnell JL; Heiser A; Highton J; Hart DN
    Arthritis Rheum; 1999 Mar; 42(3):507-18. PubMed ID: 10088774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological and biochemical characterization of bovine interleukin 2. Studies with cloned bovine T cells.
    Brown WC; Grab DJ
    J Immunol; 1985 Nov; 135(5):3184-90. PubMed ID: 3930599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparate functional properties of two interleukin 1-responsive Ly-1+2- T cell clones: distinction of T cell growth factor and T cell-replacing factor activities.
    Rao A; Mizel SB; Cantor H
    J Immunol; 1983 Apr; 130(4):1743-8. PubMed ID: 6220067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA.
    Arya SK; Wong-Staal F; Gallo RC
    J Immunol; 1984 Jul; 133(1):273-6. PubMed ID: 6427338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional properties of continuously cultured human T lymphocytes.
    Boylston AW; Anderson RL; Haworth CA
    Clin Exp Immunol; 1981 Feb; 43(2):329-35. PubMed ID: 6456095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional heterogeneity of helper T cells: two distinct helper T cells are required for the production of T cell growth factor.
    Larsson EL
    J Immunol; 1982 Feb; 128(2):742-5. PubMed ID: 6798123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased TCGF activity in the culture medium of PHA stimulated peripheral mononuclear cells from patients with metastatic cancer.
    Nakayama E; Asano S; Takuwa N; Yokota J; Miwa S
    Clin Exp Immunol; 1983 Mar; 51(3):511-6. PubMed ID: 6602018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of T cell activation. II. Antigen- and lectin-dependent acquisition of responsiveness to TCGF is a nonmitogenic, active response of resting T cells.
    Larsson EL
    J Immunol; 1981 Apr; 126(4):1323-6. PubMed ID: 6451643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell hybridoma-derived regulatory factors. I. Production of T cell growth factor following stimulation by concanavalin A.
    Schrader JW; Clark-Lewis I
    J Immunol; 1981 Mar; 126(3):1101-5. PubMed ID: 6970213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and purification of human T-lymphocyte colony-enhancing factor, TLCEF: increased production by phorbol myristate acetate.
    Werber MM; Goldman J; Radnay J; Klein S; Rozenszajn LA
    Immunology; 1985 Oct; 56(2):285-93. PubMed ID: 3876981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early supernatants of mitogen-stimulated mononuclear cells promote long-term IL-2-dependent growth of human T lymphocytes.
    Siwicki JK; Steffen JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):109-17. PubMed ID: 8915514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression by tumor growth of T cell growth factor production in mouse lymphoid cell cultures.
    Kedar E; Katz-Gross A; Chriqui-Zeira E; Bercowitz H
    J Biol Response Mod; 1984 Oct; 3(5):547-60. PubMed ID: 6334140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B cell growth factor and T cell growth factor produced by mitogen-stimulated normal human peripheral blood T lymphocytes are distinct molecules.
    Muraguchi A; Kasahara T; Oppenheim JJ; Fauci AS
    J Immunol; 1982 Dec; 129(6):2486-9. PubMed ID: 6982927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. II. Evidence for glycosylation of T cell growth factor, T cell replacing factor, and granulocyte-macrophage colony-stimulating factor.
    Clark-Lewis I; Schrader JW
    J Immunol; 1982 Jan; 128(1):175-80. PubMed ID: 6976370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.